CoChat

A telehealth lifestyle intervention to reduce excess gestational weight gain in pregnant women with overweight or obesity (GLOW): a randomised, parallel-group, controlled trial

Open access
Ferrara, Assiamira, Hedderson, Monique M, Brown, Susan D, Ehrlich, Samantha F, Tsai, Ai-Lin, Feng, Juanran, Galarce, Maren, Marcovina, Santica, Catalano, Patrick, Quesenberry, Charles P · 2020 · The Lancet Diabetes & Endocrinology
Cited by 162

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Summary Background Excess gestational weight gain (GWG) among women with overweight or obesity synergistically increases their already elevated risk of having gestational diabetes, a caesarean delivery, a large for gestational age infant, and post-partum weight retention, and increases their child’s risk of obesity. We investigated whether a primarily telehealth lifestyle intervention reduced excess GWG among women with overweight or obesity. Methods We did a randomised controlled trial in five antenatal clinics of Kaiser Permanente; Oakland, San Leandro, Walnut Creek, Fremont, and Santa Clara, CA, USA. Women at 8–15 weeks’ gestation with singletons, pre-pregnancy BMI 25.0–40.0 kg/m2, and aged 18 years or older were randomly assigned (1:1) to receive the telehealth lifestyle intervention or usual antenatal care. Randomisation was adaptively balanced for age, BMI, and race and ethnicity. Data collectors and investigators were masked to group assignments. The core lifestyle intervention consisted of two in-person and 11 telephone sessions on behavioural strategies to improve weight, diet, and physical activity, and stress management to help women meet a trial goal of gaining at the lower limit of the Institute of Medicine (IOM) guidelines range for total GWG: 7 kg for women with overweight and 5 kg for women with obesity. Usual antenatal care included an antenatal visit at 7–10 weeks’ gestation, an additional seven antenatal visits, on average, and periodic health education newsletters, including the IOM GWG guidelines and information on healthy eating and physical activity in pregnancy. The primary outcome was weekly rate of GWG expressed as excess GWG, per Institute of Medicine guidelines and mean assessed in the intention-to-treat population. The trial is registered at ClinicalTrials.gov, NCT02130232. Findings Between March 24, 2014, and Sept 26, 2017, 5329 women were assessed for eligibility and 200 were randomly assigned to the lifestyle intervention group and 198 to the usual care group. Analyses included 199 women in the lifestyle intervention group (one lost to follow-up) and 195 in the usual care group (three lost to follow-up). 96 (48%) women in the lifestyle intervention group and 134 (69%) women in the usual care group exceeded Institute of Medicine guidelines for rate of GWG per week (relative risk 0.70, 95% CI 0.59 to 0.83). Compared with usual care, women in the lifestyle intervention had reduced weekly rate of GWG (mean 0.26 kg per week [SD 0.15] vs 0.32 kg per week [0.13]; mean between-group difference –0.07 kg per week, 95% CI –0.09 to –0.04). No between-group differences in perinatal complications were observed. Interpretation Our evidence-based programme showed that health-care delivery systems could further adapt to meet the needs of their clinical settings to prevent excess GWG and improve healthy behaviours and markers of insulin resistance among women with overweight or obesity by using telehealth lifestyle interventions. Funding US National Institutes of Health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(20)30107-8

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 17

  1. 2016, QuickStats: gestational weight gain among women with full-term, singleton births, compared with recommendations—48 states and the district of Columbia, 2015, MMWR Morb Mortal Wkly Rep, 65
  2. Goldstein, 2017, Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis, JAMA, 317, 2207, 10.1001/jama.2017.3635 · DOI · Paper page
  3. Sridhar, 2014, Maternal gestational weight gain and offspring risk for childhood overweight or obesity, Am J Obstet Gynecol, 211, 259.e1, 10.1016/j.ajog.2014.02.030 · DOI · Paper page
  4. Vesco, 2014, Efficacy of a group-based dietary intervention for limiting gestational weight gain among obese women: a randomized trial, Obesity, 22, 1989, 10.1002/oby.20831 · DOI · Paper page
  5. Peaceman, 2018, Lifestyle interventions limit gestational weight gain in women with overweight or obesity: LIFE-moms prospective meta-analysis, Obesity, 26, 1396, 10.1002/oby.22250 · DOI · Paper page
  6. Yeo, 2016, Challenges of integrating an evidence-based intervention in health departments to prevent excessive gestational weight gain among low-income women, Public Health Nurs, 33, 224, 10.1111/phn.12255 · DOI
  7. Ferrara, 2012, Referral to telephonic nurse management improves outcomes in women with gestational diabetes, Am J Obstet Gynecol, 206, 491, 10.1016/j.ajog.2012.04.019 · DOI · Paper page
  8. Brown, 2019, Gestational weight gain and optimal wellness (GLOW): rationale and methods for a randomized controlled trial of a lifestyle intervention among pregnant women with overweight or obesity, BMC Pregnancy Childbirth, 19, 145, 10.1186/s12884-019-2293-8 · DOI
  9. Saghaei, 2011, Implementation of an open-source customizable minimization program for allocation of patients to parallel groups in clinical trials, J Biomed Sci Eng, 4, 734, 10.4236/jbise.2011.411090 · DOI · Paper page
  10. Aris, 2019, A 2017 US reference for singleton birth weight percentiles using obstetric estimates of gestation, Pediatrics, 144, 10.1542/peds.2019-0076 · DOI · Paper page
  11. Zou, 2004, A modified poisson regression approach to prospective studies with binary data, Am J Epidemiol, 159, 702, 10.1093/aje/kwh090 · DOI · Paper page
  12. Raab, 2000, How to select covariates to include in the analysis of a clinical trial, Control Clin Trials, 21, 330, 10.1016/S0197-2456(00)00061-1 · DOI · Paper page
  13. Koivusalo, 2016, Gestational diabetes mellitus can be prevented by lifestyle intervention: the Finnish gestational diabetes prevention study (RADIEL): a randomized controlled trial, Diabetes Care, 39, 24, 10.2337/dc15-0511 · DOI · Paper page
  14. Moran, 2017, The effect of an antenatal lifestyle intervention in overweight and obese women on circulating cardiometabolic and inflammatory biomarkers: secondary analyses from the LIMIT randomised trial, BMC Med, 15, 32, 10.1186/s12916-017-0790-z · DOI
  15. Hattersley, 1998, Mutations in the glucokinase gene of the fetus result in reduced birth weight, Nat Genet, 19, 268, 10.1038/953 · DOI · Paper page
  16. Broskey, 2017, Early pregnancy weight gain exerts the strongest effect on birth weight, posing a critical time to prevent childhood obesity, Obesity, 25, 1569, 10.1002/oby.21878 · DOI
  17. Katzmarzyk, 2014, An evolving scientific basis for the prevention and treatment of pediatric obesity, Int J Obes, 38, 887, 10.1038/ijo.2014.49 · DOI

Cited by

See all 162

Metadata

Authors
Ferrara, A., Hedderson, M. M., Brown, S. D., Ehrlich, S. F., Tsai, A.-L., Feng, J., Galarce, M., Marcovina, S., Catalano, P., & Quesenberry, C. P.
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2020-06
Volume
8
Issue
6
Pages
490-500
ISSN
2213-8587 (ISSN-L)
OpenAlex
W3027770756
Cited by
162
References
9
FWCI
10.00
Type
journal article
Language
en
Update notices
erratum (2023-04-01)
Open access
green
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (K01 DK099404, P30 DK092924)
  • Kaiser Permanente
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD073572)
  • Society for Endocrinology (K01 DK105106)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A telehealth lifestyle intervention to reduce excess gestational weight gain in pregnant women with overweight or obesity (GLOW): a randomised, parallel-group, controlled trial. https://app.cochat.ai/papers/10.1016/s2213-8587(20)30107-8
The paper
Ferrara, A., Hedderson, M. M., Brown, S. D., Ehrlich, S. F., Tsai, A.-L., Feng, J., Galarce, M., Marcovina, S., Catalano, P., & Quesenberry, C. P. (2020). A telehealth lifestyle intervention to reduce excess gestational weight gain in pregnant women with overweight or obesity (GLOW): a randomised, parallel-group, controlled trial. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(20)30107-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.